Skip to main content
SpringerLink
Log in

Hepatic Encephalopathy in Children

  • Chapter
  • First Online:
MR Spectroscopy of Pediatric Brain Disorders

  • 2004 Accesses

Abstract

Hepatic encephalopathy (HE) is a neurocognitive disorder associated with either acute or chronic liver disease (CLD). HE is also found in patients with either spontaneous or surgically created portosystemic shunts. The severity of HE spans from a mild neuropsychological impairment, detectable only at a psychometric evaluation, to coma. HE is a potentially reversible process. However, cirrhosis-associated neurological deficits may persist after liver transplant thus, supporting the hypothesis that HE may lead to irreversible neurological impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mechtcheriakov S, Graziadei IW, Mattedi M, Bodner T, Kugener A, Hinterhuber HH, Marksteiner J, Vogel W. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transplant. 2004;10:77–83.

    Article  Google Scholar 

  2. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190–201.

    Article  PubMed  Google Scholar 

  3. Dhawan A. Etiology and prognosis of acute liver failure in children. Liver Transpl. 2008;14 Suppl 2:S80–4.

    Article  PubMed  Google Scholar 

  4. Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol. 2010;16:3347–57.

    Article  PubMed  CAS  Google Scholar 

  5. Trey C, Davidson C. The management of fulminant hepatic failure. In: Popper H, Schaffner F, editors. Progress in liver diseases, vol. 111. New York, NY: Grun and Stratten; 1970. p. 282–98.

    Google Scholar 

  6. Baker A, Alonso ME, Aw MM, Ciocca M, Porta G, Rosenthal P. Hepatic failure and liver transplant: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39 Suppl 2:S632–9.

    Article  PubMed  Google Scholar 

  7. O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.

    Article  PubMed  Google Scholar 

  8. Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14 suppl 2:S67–79.

    Article  PubMed  Google Scholar 

  9. Aw MM, Dhawan A. Acute liver failure. Indian J Pediatr. 2002;69:87–91.

    Article  PubMed  Google Scholar 

  10. Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care. 2007;23:129–35.

    Article  PubMed  Google Scholar 

  11. Arora NK, Nanda SK, Gulati S, Ansari IH, Chawla MK, Gupta SD, Panda SK. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol. 1996;48:215–21.

    Article  PubMed  CAS  Google Scholar 

  12. Whittington PF. Fulminant hepatic failure in children. In: Suchy FJ, editor. Liver disease in children. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 63–88.

    Google Scholar 

  13. Flynn DM, Mohan N, McKiernan P, Beath S, Buckels J, Mayer D, Kelly DA. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatol Ed. 2003;88:F124–7.

    Article  CAS  Google Scholar 

  14. Ekong Udeme D, Kelly S, Whitington PF. Disparate clinical presentation of neonatal hemochromatosis in twins. Pediatrics. 2005;116:880–4.

    Article  Google Scholar 

  15. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet. 2004;364:1690–8.

    Article  PubMed  CAS  Google Scholar 

  16. Wang ZJ, Berry GT, Dreha SF, Segal S, Zimmerman RA. In vivo proton brain MRS of galactosemia. Ann Neurol. 2001;50:266–9.

    Article  PubMed  CAS  Google Scholar 

  17. Bijarnia S, Puri RD, Ruel J, Gray GF, Jenkinson L, Verma IC. Tyrosinemia Type I—diagnostic issues and prenatal diagnosis. Indian J Pediatr. 2006;73:63–165.

    Article  Google Scholar 

  18. Mews C, Sinatra F. Chronic liver disease in children. Pediatr Rev. 1993;14:436–43.

    PubMed  CAS  Google Scholar 

  19. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis. 2009;29:297–306.

    Article  PubMed  Google Scholar 

  20. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002;17:221–7.

    Article  PubMed  CAS  Google Scholar 

  21. Rao KV, Norenberg MD. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis. 2001;16:67–78.

    Article  PubMed  CAS  Google Scholar 

  22. Normandin L, Hazell AS. Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab Brain Dis. 2002;17:375–87.

    Article  PubMed  CAS  Google Scholar 

  23. Hazell AS. Astrocytes and manganese neurotoxicity. Neurochem Int. 2002;41:271–7.

    Article  PubMed  CAS  Google Scholar 

  24. Rose C, Butterworth RF, Zayed J, Todd K, Michalak A, Spahr L, Huet PM, Pomier-Layrargues G. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology. 1999;117:640–4.

    Article  PubMed  CAS  Google Scholar 

  25. Bicknese AR, May W, Hickey WF, Dodson WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol. 1992;32:767–75.

    Article  PubMed  CAS  Google Scholar 

  26. Genovese E, Maghnie M, Maggiore G, Tinelli C, Lizzoli F, De Giacomo C, Pozza S, Campani R. MR Imaging of CNS involvement in children affected by chronic liver disease. AJNR Am J Neuroradiol. 2000;21:845–51.

    PubMed  CAS  Google Scholar 

  27. Zuccoli G, Siddiqui N, Cravo I, Bailey A, Gallucci M, Harper C. Neuroimaging findings in alcoholic encephalopathies. AJR Am J Roentenol. 2010;195:1378–84.

    Article  Google Scholar 

  28. Bindu PS, Sinha S, Taly AB, Christopher R, Kovoor JME. Cranial MRI in acute hyperammonemic encephalopathy. Pediatr Neurol. 2009;41:139–42.

    Article  PubMed  Google Scholar 

  29. McKinney AM, Lohman BD, Sarikaya B, Uhlmann E, Spanbauer J, Singewald T, Brace JR. Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. Am J Neuroradiol. 2010;31:1471–9.

    Article  PubMed  CAS  Google Scholar 

  30. Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol. 2008;103:1413–20.

    Article  PubMed  Google Scholar 

  31. Kumar R, Gupta RK, Elderkin-Thompson V, Huda A, Sayre J, Kirsch C, Guze B, Han S, Thomas MA. Voxel-based diffusion tensor magnetic resonance imaging evaluation of low-grade hepatic encephalopathy. J Magn Reson Imaging. 2008;27(5):1061–8.

    Article  PubMed  Google Scholar 

  32. Goel A, Yadav S, Saraswat V, Srivastava A, Thomas MA, Pandey CM, Rathore R, Gupta R. Cerebral oedema in minimal hepaticencephalopathy due to extrahepatic portalvenous obstruction. Liver Int. 2010;30(8):1143–51.

    Article  PubMed  CAS  Google Scholar 

  33. Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging. 2008;28:334–41.

    Article  PubMed  Google Scholar 

  34. Mardini H, Smith FE, Record CO, Blamire AM. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol. 2011;54(6):1154–60.

    Article  PubMed  CAS  Google Scholar 

  35. Rovira A, Córdoba J, Raguer N, Alonso J. Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation. Curr Opin Neurol. 2002;15:731–7.

    Article  PubMed  Google Scholar 

  36. Atlas SW (2009) Magnetic resonance spectroscopy and the biochemical basis of neurologic disease. In Eva MR, Gilberto González R (Eds.) Magnetic resonance imaging of the brain and spine, 4th Edn (1844–1845). Philadelphia: Lippincott Williams & Wilkins; 2009

    Google Scholar 

  37. Foerster BR, Conklin LS, Petrou M, Barker PB, Schwarz KB. Minimal hepatic encephalopathy in children: evaluation with proton MR spectroscopy. AJNR Am J Neuroradiol. 2009;30:1610–13.

    Article  PubMed  CAS  Google Scholar 

  38. Sijens P, Alkefaji H, Lunsing R, Spronsen F, Meiners L, Oudkerk M, Verkade M. Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure. Eur Radiol. 2008;18:2601–9.

    Article  PubMed  Google Scholar 

  39. Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int. 2008;28(8):1095–103.

    Article  PubMed  CAS  Google Scholar 

  40. Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. J Gastroenterol Hepatol. 2008;23:e111–9.

    Article  PubMed  CAS  Google Scholar 

  41. Cordoba J, Olive G, Alonso J, Rovira A, Segarra A, Perez M, Jacas C, Vargas V. Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J Hepatol. 2001;34:176–8.

    PubMed  CAS  Google Scholar 

  42. Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, Kaiser S, Mader I, et al. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology. 2000;216:683–91.

    PubMed  CAS  Google Scholar 

  43. Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H- magnetic resonance abnormalities after liver transplantation. J Hepatol. 2001;35:598–604.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Children Hospital of Pittsburgh at the University of Pittsburgh Medical Center, Pittsburgh, PA, 15224, USA

    Giulio Zuccoli MD & Gayathri Sreedher MD

Authors
  1. Giulio Zuccoli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gayathri Sreedher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giulio Zuccoli MD .

Editor information

Editors and Affiliations

  1. Keck School of Medicine, Dept. Radiology, University of Southern California, Zonal Avenue 1975, Los Angeles, 90089-9034, California, USA

    Stefan Blüml

  2. , Dept. of Pediatric Radiology, Children's Hospital of Pittsburg of UPMC, Penn Avenue 4401, Pittsburgh, 15224, Pennsylvania, USA

    Ashok Panigrahy

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Zuccoli, G., Sreedher, G. (2013). Hepatic Encephalopathy in Children. In: Blüml, S., Panigrahy, A. (eds) MR Spectroscopy of Pediatric Brain Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5864-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5864-8_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-5863-1

  • Online ISBN: 978-1-4419-5864-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation